What happens when you take tacrolimus with schisandra?
Tacrolimus (Prograf, Envarsus XR, Astagraf XL) is an immunosuppressant used to prevent rejection after an organ transplant. Its safe range is narrow: too little allows rejection, while too much can damage the kidneys and nerves. Schisandra is a berry used in traditional Chinese medicine and sold in the US as an "adaptogen". One species, Schisandra sphenanthera, raises tacrolimus blood levels markedly, and the tacrolimus prescribing labels list its extracts in the same group as strong CYP3A inhibitors such as ketoconazole and clarithromycin.
- Much of each tacrolimus dose is normally broken down in the gut wall and liver by CYP3A enzymes, and the P-glycoprotein transporter pumps some of it back out of gut cells.
- Schisandra sphenanthera extract blocks both. In lab and rat studies, the extract almost completely stopped tacrolimus breakdown in liver microsomes and reduced P-glycoprotein pumping.
- With less tacrolimus lost on the way in, more reaches the blood. In healthy volunteers, tacrolimus exposure more than doubled on average.
- The labels warn that drugs in this group can raise tacrolimus levels quickly and sharply, raising the risk of serious side effects such as nerve toxicity and QT prolongation (a heart rhythm change).
- The reverse can happen too: stopping schisandra after a dose has been adjusted around it can let tacrolimus levels fall.
The human studies used Schisandra sphenanthera (nan wuweizi), the source of Wuzhi capsules and tablets. Many schisandra berry supplements sold in the US are labeled Schisandra chinensis. That species has not been tested with tacrolimus in people, but it contains related lignans that inhibit CYP3A in lab studies, so the same caution makes sense.
Why is this important?
Tacrolimus is dosed by blood level, and small shifts matter. An herb that more than doubles exposure can push a patient on a stable dose well above the target range without any change in the prescription.
In the healthy-volunteer study, peak tacrolimus levels rose more than threefold on average and the body cleared the drug about half as fast. The tacrolimus labels say that with strong CYP3A inhibitors, levels can rise early even after the dose is lowered, and they call for frequent level checks starting within 1 to 3 days.
The effect is strong enough that some transplant centers in China give Wuzhi capsules on purpose to raise tacrolimus levels, with close blood-level monitoring. That planned, monitored use is very different from adding a schisandra supplement on your own.
High tacrolimus levels are linked in the labels to nerve problems such as tremor, confusion and seizures, to kidney injury and to QT prolongation. Too-low levels after stopping the herb raise the risk of rejection.
What should you do?
The safe principle: do not add or remove schisandra on your own while taking tacrolimus. Any change should go through your transplant team.
Before starting: Check the labels of adaptogen, stress, energy and liver support blends for schisandra, wu wei zi, nan wuweizi or Wuzhi. Ask your transplant team or pharmacist before using any of them.
Every day while on tacrolimus: Take tacrolimus exactly as prescribed, keep your blood-level appointments and keep your team's list of supplements up to date.
After a change: If you realize you have been taking schisandra, do not simply stop and carry on. Tell your transplant team, who may want to check your level as it changes. Contact them promptly about new tremor, confusion or vision changes, which the label lists as reasons to call.
Which specific products are affected?
On the medication side, this applies to oral tacrolimus: Prograf capsules and granules, Envarsus XR tablets, Astagraf XL capsules and generic tacrolimus capsules. Tacrolimus ointment (Protopic and generics) is minimally absorbed; its label puts blood exposure at about 30-fold less than oral transplant doses, so it is far less of a concern, but still worth mentioning to your clinician.
On the herb side, the clearest evidence is for Schisandra sphenanthera products such as Wuzhi capsules and tablets. Caution also applies to schisandra berry (Schisandra chinensis, wu wei zi) capsules, powders, tinctures and teas, and to multi-herb adaptogen, stress and liver support formulas that list schisandra.
The science behind it
In a study of 12 healthy men (Xin HW, et al. Br J Clin Pharmacol. 2007), a single tacrolimus dose was given before and after 13 days of Schisandra sphenanthera extract. With the extract, tacrolimus AUC rose by an average of 164.2 percent, peak level by 227.1 percent, and apparent oral clearance fell by 49.0 percent.
A later study in healthy Chinese volunteers (Teng F, et al. Biopharm Drug Dispos. 2022) tested increasing amounts of Wuzhi capsule and found that with the capsules tacrolimus reached its peak later and was cleared more slowly, and that tacrolimus levels differed by CYP3A5 genotype. A retrospective study of 194 Chinese kidney transplant recipients (Cheng F, et al. J Clin Pharm Ther. 2021) found a higher tacrolimus concentration-to-dose ratio in patients given Wuzhi capsules, with no difference in kidney function or reported adverse reactions; it was retrospective and described planned, monitored use.
Laboratory and rat work (Qin XL, et al. Int J Pharm. 2010) showed the extract inhibits P-glycoprotein and CYP3A, and that reduced breakdown in the gut wall was the main reason more tacrolimus was absorbed. The Prograf and Envarsus XR labels list Schisandra sphenanthera extracts among strong CYP3A inhibitors that may raise tacrolimus levels.
What has not been shown: no study has tested Schisandra chinensis with tacrolimus in people, and no study tested whether spacing doses helps. A 2026 review (Jeyaraj G. Drug Metab Rev.) notes that S. chinensis lignans inhibit CYP3A in lab work, that the strongest clinical evidence is for Wuzhi preparations, and that direct human evidence remains limited.
Frequently Asked Questions
Is schisandra berry the same as the Wuzhi capsules in the studies?
Not exactly. Wuzhi is made from Schisandra sphenanthera, while many schisandra berry supplements are Schisandra chinensis. The two contain related lignans, and S. chinensis has not been tested with tacrolimus in people, so treat both with the same caution.
Can I take schisandra a few hours apart from tacrolimus?
Spacing has not been studied and is unlikely to help, because the herb blocks the enzymes and transporter that clear tacrolimus. Ask your transplant team before using it at all.
Why do some doctors give Wuzhi capsules with tacrolimus on purpose?
Some transplant centers in China use it to raise tacrolimus levels, with frequent blood tests. That shows how strong the effect is. It is a planned decision by the transplant team, not something to copy on your own.
What if I have already been taking schisandra?
Tell your transplant team. Do not stop it on your own, because your level may fall when the herb is removed and your team may want to check it.
Does this matter for tacrolimus ointment?
Much less. The ointment is minimally absorbed into the blood. Still, mention any supplement to the clinician who prescribes it.
How would I know my tacrolimus level is too high?
Often you would not, which is why blood tests matter. The label asks patients to contact their doctor about tremor, confusion or vision changes.
Key takeaways
- Schisandra sphenanthera (Wuzhi) extract more than doubled tacrolimus exposure in healthy volunteers.
- The tacrolimus labels list Schisandra sphenanthera extracts with the strong CYP3A inhibitors.
- Schisandra chinensis berry supplements have not been tested with tacrolimus in people, but they contain related CYP3A-blocking lignans.
- Check adaptogen, stress and liver blends for schisandra, wu wei zi or Wuzhi.
- Do not start or stop schisandra on your own; your transplant team may need to check your level.
